دورية أكاديمية
Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study
| العنوان: | Using Wearable Inertial Sensors to Assess Mobility of Patients With Hematologic Cancer and Associations With Chemotherapy-Related Symptoms Before Autologous Hematopoietic Stem Cell Transplant: Cross-sectional Study |
|---|---|
| المؤلفون: | Meghan B Skiba, Graham Harker, Carolyn Guidarelli, Mahmoud El-Gohary, Fay Horak, Eric J Roeland, Rebecca Silbermann, Brandon Hayes-Lattin, Kerri Winters-Stone |
| المصدر: | JMIR Cancer, Vol 8, Iss 4, p e39271 (2022) |
| بيانات النشر: | JMIR Publications |
| سنة النشر: | 2022 |
| المجموعة: | Directory of Open Access Journals: DOAJ Articles |
| مصطلحات موضوعية: | Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
| الوصف: | BackgroundWearable sensors could be a simple way to quantify and characterize mobility in patients with hematologic cancer scheduled to receive autologous hematopoietic stem cell transplant (autoHSCT) and how they may be related to common treatment-related symptoms and side effects of induction chemotherapy. ObjectiveWe aimed to conduct a cross-sectional study comparing mobility in patients scheduled to receive autoHSCT with that in healthy, age-matched adult controls and determine the relationships between patient mobility and chemotherapy-related symptoms. MethodsPatients scheduled to receive autoHSCT (78/156, 50%) and controls (78/156, 50%) completed the prescribed performance tests using wearable inertial sensors to quantify mobility including turning (turn duration and number of steps), gait (gait speed, stride time, stride time variability, double support time, coronal trunk range of motion, heel strike angle, and distance traveled), and balance (coronal sway, coronal range, coronal velocity, coronal centroidal frequency, sagittal sway, sagittal range, sagittal velocity, and sagittal centroidal frequency). Patients completed the validated patient-reported questionnaires to assess symptoms common to chemotherapy: chemotherapy-induced peripheral neuropathy (Functional Assessment of Cancer Therapy/Gynecologic Oncology Group–Neurotoxicity subscale), nausea and pain (European Organization for Research and Treatment of Cancer Quality of Life Questionnaire), fatigue (Patient-Reported Outcomes Measurement Information System Fatigue Short Form 8a), vertigo (Vertigo Symptom Scale–short form), and depression (Center for Epidemiological Studies–Depression). Paired, 2-sided t tests were used to compare mobility between patients and controls. Stepwise multivariable linear regression models were used to evaluate associations between patient mobility and symptoms. ResultsPatients aged 60.3 (SD 10.3) years had significantly worse turning (turn duration; P<.001), gait (gait speed, stride time, stride time variability, ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 2369-1999 |
| العلاقة: | https://cancer.jmir.org/2022/4/e39271Test; https://doaj.org/toc/2369-1999Test; https://doaj.org/article/057089b872794dea8e22a34480be76e2Test |
| DOI: | 10.2196/39271 |
| الإتاحة: | https://doi.org/10.2196/39271Test https://doaj.org/article/057089b872794dea8e22a34480be76e2Test |
| رقم الانضمام: | edsbas.E01AC149 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 23691999 |
|---|---|
| DOI: | 10.2196/39271 |